Biotechnology sector at a low
The Corona pandemic had caused sales in the German biotech industry to soar for two years in a row. Just as great was the willingness of companies to invest in research and development (R&D) and create new jobs. Vaccine developers such as BioNTech and CureVac in particular had determined the record growth. Now, the annual survey of the industry association BIO Deutschland revealed a rather pessimistic picture.